PHM

PulteGroup

$119.71

-1.58%
Oct 28, 2026
Bobby Quantitative Model
PulteGroup is one of the largest U.S. homebuilders, constructing single-family detached homes for entry-level, move-up, and active-adult buyers under its Pulte, Centex, and Del Webb brands, and complementing construction with a financial services arm offering mortgage financing, title, and insurance agency services. The company is a scale incumbent in a highly cyclical, land-intensive industry, distinguished by a consumer-segmented brand portfolio, a build-to-order model, and one of the strongest balance sheets in residential construction. The current investor narrative is dominated by the affordability shock: mortgage rates pushed above 7% on surging Treasury yields, pressuring order volumes and forcing the company to lean on incentives, which has driven gross margins down sharply year over year and turned the debate into a valuation-versus-cycle question. Bulls point to a discounted multiple, a fortress balance sheet, and structural housing undersupply, while bears argue that margin compression and demand destruction are far from finished, a tension reflected in the stock's flat one-year return and underperformance versus the S&P 500.

People also watch

D. R. Horton

D. R. Horton

DHI

Analysis
Lennar Corporation

Lennar Corporation

LEN

Analysis
Toll Brothers

Toll Brothers

TOL

Analysis
Taylor Morrison

Taylor Morrison

TMHC

Analysis
INSTALLED BUILDING PRODUCTS, INC.

INSTALLED BUILDING PRODUCTS, INC.

IBP

Analysis

BobbyInvestment Opinion: Should I buy PHM Today?

Rating: Hold with a positive bias. The core thesis is that PHM offers deep value (10.3x forward EPS) and a fortress balance sheet (D/E 0.185) that provides downside protection, but near-term earnings headwinds from margin compression and high mortgage rates limit upside until the housing cycle turns. Analyst consensus is 'buy' with an average target of $134.47, implying 11% upside, but the stock's recent underperformance (-5.9% over 3 months) suggests patience is warranted.

Supporting evidence: 1) Valuation is attractive at 10.3x forward EPS and 1.79x book, well below historical averages; 2) Revenue growth is negative (-9.6% YoY) but expected to stabilize as the company laps tough comparisons; 3) Profitability remains solid with a 12.8% net margin and 17.1% ROE, despite compression; 4) Free cash flow of $1.51 billion supports buybacks and dividends; 5) The average analyst target of $134.47 offers 11% upside, with a high target of $162 (34% upside).

Risks: The biggest risks are a continued rise in mortgage rates, further margin erosion, and a prolonged housing downturn. The rating would upgrade to Buy if gross margins stabilize above 20% and mortgage rates show signs of peaking, or downgrade to Sell if gross margins fall below 18% or revenue declines accelerate beyond 15%. Valuation verdict: fairly valued to slightly undervalued relative to history and peers, but the market is pricing in a cyclical downturn; a catalyst is needed for re-rating.

Sign up to view all

PHM 12-Month Price Forecast

The risk/reward is balanced: valuation is attractive and the balance sheet is rock-solid, but near-term earnings headwinds from high mortgage rates and margin compression are likely to persist. The stock could trade in a range of $107-$140 over the next 12 months, with the base case (50% probability) targeting $125-$140. An upgrade to bullish would require evidence of margin stabilization and a peak in mortgage rates; a downgrade to bearish would follow a break below the 52-week low of $107.16 or a further deterioration in gross margins below 18%.

Historical Price
Current Price $119.71
Average Target $132.50
High Target $162.00
Low Target $100.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on PulteGroup's 12-month outlook, with a consensus price target around $132.88 and implied upside of +11.0% versus the current price.

Average Target

$132.88

0 analysts

Implied Upside

+11.0%

vs. current price

Analyst Count

—

covering this stock

Price Range

$100 - $162

Analyst target range

Drowning in data?

Find the real signal!

Bulls vs Bears: PHM Investment Factors

The bear case currently has stronger near-term evidence: revenue is declining 9.6% YoY, gross margins have collapsed 650 basis points, and mortgage rates above 7% show no quick fix. However, the bull case rests on a fortress balance sheet (D/E 0.185), deep value (10.3x forward EPS), and a structural housing shortage that should eventually reassert itself. The single most important tension is whether margin compression has bottomed; if gross margins stabilize above 20%, the stock could re-rate sharply toward the $134 average target, but further erosion would validate the bear thesis and test the $100 low target. Analyst consensus remains constructive with an 11% upside to the average target, suggesting the risk/reward is skewed positively for patient investors.

Bullish

  • Deep value on forward earnings: At $121.19, PHM trades at just 10.3x forward EPS of $11.80 and 1.79x book value, a discount that already prices in a meaningful earnings decline. The trailing P/E of 10.46x and EV/EBITDA of 7.8x are well below the market multiple, offering a margin of safety if housing stabilizes.
  • Fortress balance sheet: Debt-to-equity is only 0.185 and the current ratio is a staggering 5.91, reflecting a cash-rich, conservatively financed builder. This liquidity allows PHM to absorb a prolonged downturn, buy land opportunistically, and sustain its dividend (yield 0.76%) without financial distress.
  • Analyst consensus sees upside: 17 analysts rate the stock a 'buy' (mean 2.11) with an average target of $134.47, implying 11% upside from $121.19. The high target of $162 suggests 34% potential, and even the low target of $100 is only 17% below current levels, indicating limited downside relative to upside.
  • Structural housing shortage: Decades of underbuilding have created a persistent supply deficit, supporting long-term demand for new homes. PHM's focus on entry-level and active-adult segments positions it to capture demographic tailwinds, and its build-to-order model reduces speculative inventory risk.

Bearish

  • Margin compression accelerating: Gross margin fell from 27.2% in Q2 2025 to 20.7% in Q2 2026, a 650-basis-point collapse, while operating margin dropped from 18.3% to 11.1%. This trend reflects heavy incentives needed to offset mortgage rates above 7%, and there is no clear sign of stabilization.
  • Revenue and earnings declining: Q2 2026 revenue fell 9.6% year-over-year to $3.98 billion, and EPS dropped from $3.03 to $2.46. The Zacks article notes expected earnings and revenue drops, and the PEG ratio of -0.43 signals negative growth expectations, which could pressure the stock further if the downturn deepens.
  • Mortgage rate headwind persists: Surging Treasury yields have pushed mortgage rates above 7%, directly hurting affordability and demand. Recent news highlights that rising yields are 'killing' housing stocks, and with the Fed potentially hiking, relief may be distant, keeping a lid on order volumes and pricing power.
  • Relative underperformance: PHM has lagged the S&P 500 significantly: 1-year relative strength is -12.9% and 6-month is -11.4%, with the stock down 5.9% over three months versus a 2.85% gain for the SPY. This weak momentum could persist as investors favor other sectors.

PHM Technical Analysis

Beta

1.16

1.16x market volatility

Max Drawdown

-23.3%

Largest decline past year

52-Week Range

$107-$145

Price range past year

Annual Return

-0.9%

Cumulative gain past year

PeriodPHM ReturnS&P 500
1m+0.5%+0.9%
3m-7.0%+4.1%
6m+0.4%+7.2%
1y-0.9%+12.4%
ytd+0.5%+13.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

PHM Fundamental Analysis

Quarterly Revenue

$4.0B

2026-06

Revenue YoY Growth

-9.6%

YoY Comparison

Gross Margin

20.7%

Latest Quarter

Free Cash Flow

$1.5B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Financial Service
Home Building Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is PHM Overvalued?

PE

10.5x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 3x~16x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

7.8x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are centered on margin compression and revenue decline. Gross margin fell from 27.2% in Q2 2025 to 20.7% in Q2 2026, and operating margin halved from 18.3% to 11.1%, driven by higher incentives and land costs. Revenue dropped 9.6% YoY in Q2 2026 to $3.98 billion, and EPS fell from $3.03 to $2.46, indicating earnings volatility. While the balance sheet is strong (debt-to-equity 0.185, current ratio 5.91), the company's profitability is highly sensitive to housing cycle turns, and continued margin erosion could pressure returns on equity (currently 17.1%) and free cash flow ($1.51 billion TTM).

Market and competitive risks include valuation compression and macro sensitivity. PHM trades at 10.3x forward EPS, which is low but could remain depressed if mortgage rates stay above 7%, as highlighted by recent news. The stock's beta is not provided, but its 1-year relative strength of -12.9% versus the S&P 500 shows it is out of favor. Competitive pressures from other builders offering incentives, and potential regulatory changes affecting housing affordability, add to the uncertainty. Sector rotation away from cyclicals could further weigh on the shares.

Worst-case scenario: a sustained rise in mortgage rates above 8%, a recession that spikes unemployment, and a sharp decline in home prices would force PHM to increase incentives further, crushing margins and earnings. The stock could fall to its 52-week low of $107.16 (a 11.6% decline from $121.19) or even the analyst low target of $100 (a 17.5% decline). Given the max drawdown of -23.3% over the past year, a drop to $93 (the 52-week low adjusted for the drawdown) is plausible in a severe downturn, representing a 23% loss from current levels.

FAQ

The most severe risk is continued margin compression: gross margin fell 650 basis points YoY to 20.7%, and further erosion could crush earnings. Second, mortgage rates above 7% pose a macro headwind, as highlighted by recent news that rising yields are 'killing' housing stocks. Third, revenue is declining (-9.6% YoY), and a recession could accelerate demand destruction. Fourth, the stock has underperformed the S&P 500 by 12.9% over the past year, and momentum could remain negative. The strong balance sheet mitigates financial risk, but cyclical and market risks are high.

Our 12-month forecast has three scenarios: Bull (25% probability) targets $145-$162 if mortgage rates fall and margins stabilize; Base (50%) targets $125-$140 with rates near 7% and margins around 20%; Bear (25%) targets $100-$107 if rates rise above 7.5% and margins fall below 18%. The base case is most likely, implying ~3-15% upside from $121.19. The key assumption is that gross margins bottom near 20% and revenue declines moderate. Analyst average target of $134.47 aligns with our base case.

PHM appears undervalued on most metrics: its forward P/E of 10.3x is below the market average and its own historical range, while the price-to-book of 1.79x is modest for a homebuilder with a 17.1% ROE. The EV/EBITDA of 7.8x and P/S of 1.34x also suggest a discount. However, the negative PEG ratio of -0.43 reflects expected earnings declines, so the low multiple may be a value trap if the cycle worsens. Relative to peers, PHM's valuation is in line to slightly cheap, but the market is pricing in cyclical risk. A re-rating would require evidence of margin stabilization and a peak in mortgage rates.

PHM offers an attractive risk/reward for value investors: it trades at 10.3x forward EPS, has a fortress balance sheet (debt-to-equity 0.185), and analysts see 11% upside to the $134.47 average target. However, the near-term outlook is challenged by a 9.6% revenue decline and gross margin compression from 27.2% to 20.7%, with mortgage rates above 7% suppressing demand. The biggest downside risk is a drop to the $100 low target (-17.5%) if margins deteriorate further. For patient investors with a 2-3 year horizon, PHM is a good buy on weakness, but near-term traders may want to wait for a margin stabilization signal.

PHM is better suited for long-term investors (minimum 2-3 years) who can ride out the housing cycle, given its cyclical nature and current earnings headwinds. The stock's beta is not provided, but its 23.3% max drawdown and 12.9% underperformance vs. the S&P 500 over the past year indicate high volatility. The dividend yield is low at 0.76%, so income is not a major draw. Short-term traders might find opportunities around earnings or mortgage rate movements, but the risk of further margin compression makes timing difficult. A buy-and-hold approach with a focus on the structural housing shortage is most appropriate.